|
|
| | AB-PINACA-d9 Basic information |
| Product Name: | AB-PINACA-d9 | | Synonyms: | AB-PINACA-d9;(S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(pentyl-2,2',3,3',4,4',5,5,5-d9)-1H-indazole-3-carboxamide | | CAS: | 2484976-98-7 | | MF: | C18H17D9N4O2 | | MW: | 339.480096002 | | EINECS: | | | Product Categories: | | | Mol File: | 2484976-98-7.mol |  |
| | AB-PINACA-d9 Chemical Properties |
| solubility | DMF: 12 mg/ml
DMSO: 12 mg/ml
DMSO: PBS (pH 7.2) (1:8): 0.11 mg/ml
Ethanol: 10 mg/ml |
| | AB-PINACA-d9 Usage And Synthesis |
| Description | AB-PINACA-d9 (exempt preparation) (Item No. 22859) is intended for use as an internal standard for the quantification of AB-PINACA (Item Nos. 14038 | ISO60210) by GC- or LC-MS. AB-PINACA is categorized as a cannabinoid.1 AB-PINACA is regulated as a Schedule I compound in the United States. AB-PINACA-d9 (exempt preparation) (Item No. 22859) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | | References | [1] N. UCHIYAMA. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products[J]. Forensic Toxicology, 2012, 31 1: 93-100. DOI: 10.1007/s11419-012-0171-4 |
| | AB-PINACA-d9 Preparation Products And Raw materials |
|